Condition

Central Nervous System Neoplasms

ClinicalTrials.gov condition label

Clinical trials3

Recruiting1

Common interventions4

Lead sponsors shown3

Clinical trials

3 shown

Study of Abemaciclib and Elacestrant in Participants With Brain Metastasis Due to ER+/HER-2- Breast CancerNCT05386108 · 2022-08-31

RECRUITING

Assessing the Suitability of an Imaging Probe for Use in Clinical Cell and Gene Therapy Trials in Cancer and Rheumatoid ArthritisNCT00185848 · 2005-04-01

COMPLETED

Safety Study of High Dose Temozolomide to Treat Relapsed/Refractory Central Nervous System (CNS) MalignancyNCT00629187 · 2004-04-01

TERMINATED

Common interventions

[18F]FHBGRADIATION1AbemaciclibDRUG1ElacestrantDRUG1TemozolomideDRUG1

Leading sponsors

Sanjiv Sam Gambhir1Stemline Therapeutics, Inc.1Tufts Medical Center1

Trial status mix

COMPLETED1

RECRUITING1

TERMINATED1

Phase mix

PHASE13

PHASE21

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.